Showing 201 - 220 results of 100,582 for search '(( 5 non decrease ) OR ( 5 ((((wt decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.51s Refine Results
  1. 201

    Spatial training decreases endogenous PTEN ubiquitination and <i>Pten</i> cKO mice show impaired spatial learning and memory. by Wei-Lun Hsu (1756123)

    Published 2023
    “…Endogenous PTEN ubiquitination level is decreased in Nedd4 siRNA-transfected rats (t<sub>1,6</sub> = 5.92, <i>p</i> = 0.001). …”
  2. 202

    Effect of Acidic Polymers on the Morphology of Laser-Induced Nucleation of Cesium Chloride by Yao Liu (173014)

    Published 2021
    “…An approach to controlling morphology and size is presented through the combination of laser-induced nucleation and polymer additives. Here, we apply the technique of non-photochemical laser-induced nucleation to irradiate a supersaturated solution (<i>S</i> = 1.15) of cesium chloride (CsCl). …”
  3. 203

    Effect of Acidic Polymers on the Morphology of Laser-Induced Nucleation of Cesium Chloride by Yao Liu (173014)

    Published 2021
    “…An approach to controlling morphology and size is presented through the combination of laser-induced nucleation and polymer additives. Here, we apply the technique of non-photochemical laser-induced nucleation to irradiate a supersaturated solution (<i>S</i> = 1.15) of cesium chloride (CsCl). …”
  4. 204
  5. 205
  6. 206
  7. 207
  8. 208

    CD43<sup>-/-</sup> septic mice exhibit decreased frequencies of apoptotic CD8<sup>+</sup> T<sub>EM</sub> as compared to WT septic mice. by Katherine T. Fay (2576998)

    Published 2018
    “…D) There was a significant decrease in apoptosis of CD44<sup>HI</sup> CD62L<sup>LO</sup> CD8<sup>+</sup> T<sub>EM</sub> in CD43<sup>-/-</sup> septic mice compared to WT septic mice (10.3±1.1 vs 17.9±1.9, p = 0.006). …”
  9. 209
  10. 210
  11. 211

    Table_1_Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study.docx by Ha Young Jang (1522204)

    Published 2022
    “…The cancer risk showed a tendency to decrease rapidly when LTRAs were used in high dose (aHR = 0.56, 95% CI = 0.40–0.79) or for longer durations of more than 3 years (aHR = 0.68, 95% CI = 0.60–0.76) and 5 years (aHR = 0.33, 95% CI = 0.26–0.42). …”
  12. 212
  13. 213
  14. 214

    p35 siRNA knockdown decreased Cdk5 activity, diminished WT1 expression and viable cell numbers, but did not affect a cell apoptosis marker as detected by WB. by Ya-Li Zheng (454837)

    Published 2016
    “…C. p35 siRNA reduced Cdk5 activity. D. Western blotting analysis showed a decline of WT1 expression in p35 siRNA podocytes (upper panel, lane 2 compared to lane 1, p = 0,048), but did not affect cleaved caspase 3 expression (middle panel, lane 2 compare with lane 1). …”
  15. 215
  16. 216
  17. 217
  18. 218

    Data_Sheet_1_Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies.docx by Dóra Mátis (15407060)

    Published 2023
    “…Background<p>Based on cross-sectional studies, there is a link between body composition parameters and steatosis in non-alcoholic fatty liver disease (NAFLD). …”
  19. 219
  20. 220

    Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue. by Wilfredo Oliva-Olivera (301968)

    Published 2017
    “…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C<sup>+</sup> and CD163<sup>+</sup> macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C<sup>+</sup>, CD163<sup>+</sup>: proinflammatory macrophage cell-surface markers.…”